MEN1 and pituitary gland adenoma: Groups did not differ in multiglandular involvement, surgical outcomes, or histopathology (p&gt;0,05).<h4>Conclusion</h4> MEN-1 exhibits marked clinical heterogeneity in the Russian population, with exon 10 mutations significantly increasing pituitary adenoma risk.